Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Boehringer Ingelheim

Last Updated: October 1, 2022

Details for New Drug Application (NDA): 022116

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

NDA 022116 describes LEXIVA, which is a drug marketed by Viiv Hlthcare and is included in two NDAs. It is available from one supplier. Additional details are available on the LEXIVA profile page.

The generic ingredient in LEXIVA is fosamprenavir calcium. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the fosamprenavir calcium profile page.
Summary for 022116
Applicant:Viiv Hlthcare
Ingredient:fosamprenavir calcium
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 022116
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LEXIVA fosamprenavir calcium SUSPENSION;ORAL 022116 NDA ViiV Healthcare Company 49702-208 49702-208-53 225 mL in 1 BOTTLE (49702-208-53)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;ORALStrengthEQ 50MG BASE/ML
Approval Date:Jun 14, 2007TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.